Carmine Foods Inc CARM 深 滬
交易中 09-20 13:41:15 美东时间
1.01
+0.029
+3.00%
華盛通- 最 高1.02
- 今 開0.98
- 成交量 3.97万股
- 最 低 0.98
- 昨 收 0.9806
- 總市值 4076.04万
- 52周最高 4.86
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 0.80
- 委 比 -60.00%
- 總股本 4035.68万
- 歷史最高 113.5706
- 量 比 0.68
- 振 幅 4.08%
- 歷史最低 0.0706
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Beyondspring Presented Final Data On Dublin-3 Study (2L/3L EGFR wild-type NSCLC) Focusing On Safety Outcomes At European Society For Medical Oncology
Docetaxel remains the standard of care for patients with 2L/3L NSCLC without targetable alterations despite severe neutropenia (>40%) that greatly impair patients' quality of life. Six recent phase 3 studies in
09-16 19:16
Syra Health Announces Pricing of $2.1 Million Public Offering
CARMEL, Ind., Sept. 11, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningfu...
09-12 09:15
Merchants Bancorp Appoints Sean Sievers as Chief Financial Officer
CARMEL, Ind., Sept. 11, 2024 /PRNewswire/ -- Merchants Bancorp (the "Company")(NASDAQ: MBIN) and its wholly owned subsidiary, Merchants Bank, have announced the appointment of Sean Sievers a...
09-12 04:05
Moderna, Carisma deal expands with autoimmune targets
Carisma Therapeutics (NASDAQ:CARM) announced Tuesday that its ongoing collaboration with Moderna (NASDAQ:MRNA) to develop cell therapies has been broadened to include two targets for the treatment of ...
09-10 20:01
OPENLANE Transforms Condition Reports with Actionable OBD2 Intelligence
New Code Boost IQ Exploits Data Moat to Empower US Dealers with Smarter, Faster Purchase Decisions CARMEL, Ind., Aug. 15, 2024 /PRNewswire/ -- OPENLANE, Inc. (NYSE: KAR), a leading operator ...
08-15 20:30
CARISMA Therapeutics Q2 2024 GAAP EPS $(0.27) Beats $(0.32) Estimate, Sales $9.197M Beat $3.925M Estimate
CARISMA Therapeutics (NASDAQ:CARM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 15.62 percent. This is a 44.9 percent increase over losses of $(0.49) per share
08-08 20:04
Why Are Carisma Therapeutics Shares Surging Friday?
Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.
06-29 01:59
Market-Moving News for June 28th
PTGX: 11% | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3 DJT: 16% | Trump Media & Technology Group shares are trading higher following
06-28 20:37
In-Depth Examination Of 5 Analyst Recommendations For CARISMA Therapeutics
5 analysts have expressed a variety of opinions on CARISMA Therapeutics (NASDAQ...
06-27 02:01
HC Wainwright & Co. Reiterates Buy on CARISMA Therapeutics, Maintains $8 Price Target
HC Wainwright & Co. analyst Mitchell Kapoor reiterates CARISMA Therapeutics (NASDAQ:CARM) with a Buy and maintains $8 price target.
06-27 00:22
